Skip to content

Investigator

Katherine S. Pollard

J. DAVID GLADSTONE INSTITUTES · funded by NCI, NIAID, NHLBI

Companies
4

Resolved onto their grants.

Grants
4

Federal awards on file.

Non-dilutive funding
$2.5M

Summed across those awards.

First award
Aug 15, 2021

Latest Jun 8, 2026.

Companies from this work

Pre-ticker companies the crosswalk resolved onto a grant filed under this investigator. Momentum shows for the therapeutic areas your seat covers; open a dossier for the full crosswalk.

Grant record

Federal awards filed under this investigator name, newest first. Each links to the public record where the awarding agency publishes one.

  1. R01

    Computational prediction of anti-cancer drug metabolizing enzymes in the human microbiome

    $748k

    Jun 8, 2026NCIJ. DAVID GLADSTONE INSTITUTESNIH RePORTER · 11363855 (opens the source filing in a new tab)

  2. P01

    Advanced Computational Core

    $325k

    May 11, 2026NIAIDJ. DAVID GLADSTONE INSTITUTESNIH RePORTER · 11265554 (opens the source filing in a new tab)

  3. R01

    Linking microbiome genetic variants with cardiovascular phenotypes in 50,000 individuals

    $685k

    Aug 1, 2022NHLBIJ. DAVID GLADSTONE INSTITUTESNIH RePORTER · 11122238 (opens the source filing in a new tab)

  4. P01

    Core B: Integrative Data-Science Core

    $775k

    Aug 15, 2021NIAJ. DAVID GLADSTONE INSTITUTESNIH RePORTER · 11166566 (opens the source filing in a new tab)

This page aggregates public U.S. federal grant records filed under one investigator name and the companies Biodatica has resolved onto them. Names are shown as the awarding agency filed them; grant awards are non-dilutive federal funding, not equity or valuation. Distinct people who file under the same name would appear together here. It is informational only and not investment advice. Methodology · Data sources